Cutler Group LP Global Blood Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	BUY	$32.4 - $68.18 $301,320 - $634,074	9,300 New	9,300 $73,000
Q1 2022 Apr 14, 2022	SELL	$25.68 - $35.59 $197,736 - $274,043	-7,700 Reduced 93.9%	500 $0
Q4 2021 Jan 18, 2022	BUY	$24.9 - $40.26 $131,970 - $213,378	5,300 Added 182.76%	8,200 $4,000
Q3 2021 Oct 26, 2021	BUY	$25.48 - $37.34 $68,796 - $100,818	2,700 Added 1350.0%	2,900 $0
Q2 2021 Jul 19, 2021	SELL	$32.46 - $43.42 $256,434 - $343,018	-7,900 Reduced 97.53%	200 $0
Q1 2021 Apr 26, 2021	BUY	$38.94 - $50.85 $233,640 - $305,100	6,000 Added 285.71%	8,100 $3,000
Q3 2020 Oct 27, 2020	SELL	$52.76 - $74.49 $279,628 - $394,797	-5,300 Reduced 71.62%	2,100 $8,000
Q2 2020 Jul 22, 2020	SELL	$48.73 - $81.82 $9,746 - $16,363	-200 Reduced 2.63%	7,400 $26,000
Q1 2020 May 07, 2020	SELL	$41.72 - $87.2 $442,232 - $924,320	-10,600 Reduced 58.24%	7,600 $19,000
Q4 2019 Feb 06, 2020	BUY	$45.7 - $81.86 $735,770 - $1.32 Million	16,100 Added 766.67%	18,200 $230,000
Q3 2019 Oct 28, 2019	SELL	$45.35 - $57.91 $825,370 - $1.05 Million	-18,200 Reduced 89.66%	2,100 $15,000
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $925,760 - $1.11 Million	17,600 Added 651.85%	20,300 $32,000
Q1 2019 May 10, 2019	SELL	$39.99 - $53.48 $511,872 - $684,544	-12,800 Reduced 82.58%	2,700 $24,000
Q4 2018 Feb 05, 2019	SELL	$31.54 - $46.67 $160,854 - $238,017	-5,100 Reduced 24.76%	15,500 $18,000
Q3 2018 Nov 07, 2018	BUY	$38.0 - $51.1 $110,200 - $148,190	2,900 Added 16.38%	20,600 $33,000
Q2 2018 Aug 10, 2018	SELL	$38.7 - $50.15 $208,980 - $270,810	-5,400 Reduced 23.38%	17,700 $80,000
Q1 2018 May 11, 2018	BUY	$39.6 - $65.9 $154,440 - $257,010	3,900 Added 20.31%	23,100 $156,000
Q4 2017 Jan 17, 2018	BUY	$29.7 - $45.7 $478,170 - $735,770	16,100 Added 519.35%	19,200 $129,000
Q3 2017 Oct 17, 2017	BUY	$25.1 - $31.05 $77,810 - $96,255	3,100	3,100 $20,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account